Side-by-side comparison of AI visibility scores, market position, and capabilities
Natura &Co (B3: NTCO3)-owned global direct-selling beauty brand with 6M+ Representatives; competing with Mary Kay and L'Oreal for Latin American mass beauty through social selling model post-2020 acquisition.
Avon is a global direct-selling beauty brand — operating primarily across Latin America and international emerging markets — selling cosmetics, skincare, fragrance, and personal care products through 6+ million independent Avon Representatives who earn income through personal sales and team building. Founded in 1886 in New York by David McConnell and pioneering the direct-selling model that enabled women to earn income as entrepreneurs, Avon Products was acquired in 2020 by Brazil's Natura &Co (B3: NTCO3) for $3.7 billion, joining a portfolio with Natura (Brazil's leading direct-selling cosmetics brand) and integrating Avon's global Representative network with Natura's digital commerce capabilities.
Richmond VA tobacco and nicotine (NYSE: MO) ~$9.7B net revenue FY2024; Marlboro 40%+ US cigarette share, on! oral pouch competing with Zyn, 50%+ operating margins, ABI stake, competing with Reynolds/BAT.
Altria Group, Inc. is a Richmond, Virginia-based tobacco and nicotine company — publicly traded on the New York Stock Exchange (NYSE: MO) as an S&P 500 Consumer Staples component — manufacturing and selling cigarettes (Marlboro — the best-selling cigarette brand in the United States), smokeless tobacco (Copenhagen, Skoal, Red Seal, Husky chewing tobacco/moist snuff brands), oral nicotine pouches (on! brand), and maintaining a 10.7% ownership stake in Anheuser-Busch InBev (SABMiller acquisition consideration shares) and a 35% stake in JUUL Labs (vaping — original $12.8B investment written down to minimal value following JUUL's regulatory and litigation difficulties) through approximately 5,500 employees. In fiscal year 2024, Altria reported revenues of approximately $20.6 billion (net revenues after excise taxes approximately $9.7 billion), with the cigarette segment (Marlboro generating 40%+ US cigarette market share) contributing the majority of operating income at 50%+ adjusted operating margins — the highest margins in the consumer staples sector reflecting cigarettes' inelastic demand and regulated market structure. CEO Billy Gifford has pivoted Altria's strategy from cigarettes toward smoke-free nicotine products: the on! oral nicotine pouch (acquired full ownership of Helix Innovations in 2023, rebranding as on! to compete with Swedish Match Zyn, the dominant US oral nicotine pouch brand) represents Altria's primary nicotine product diversification vehicle as cigarette volume declines 7-8% annually through consumer quit rates and secular health awareness trends.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.